Financials
| Q3 Trading Update | Apr. 10, 2025 |
| Half-year Report | Mar. 18, 2025 |
| Trading Update | Jan. 27, 2025 |
| Audited Full Year Fiscal 2024 Results | Nov. 21, 2024 |
| Financial Results for Q1 of Fiscal Year 2025 | Nov. 20, 2024 |
| Audited US GAAP financial results | Oct. 01, 2024 |
| Renalytix Reports Financial Results for Q3 FY2024 | May. 15, 2024 |
Proxies
| Publication of Annual Report and Notice of AGM | Nov. 26, 2024 |
| Result of AGM | Dec. 15, 2023 |
| Publication of Annual Report 2023 & Notice of AGM | Nov. 17, 2023 |
| Result of AGM | Dec. 19, 2022 |
| Result of AGM | Dec. 17, 2021 |
Ownership Update
| Holding(s) in Company | Oct. 17, 2025 |
| Holding(s) in Company | Oct. 17, 2025 |
| Holding(s) in Company | Oct. 16, 2025 |
| Holding(s) in Company | Oct. 16, 2025 |
| Holding(s) in Company | Oct. 15, 2025 |
| Holding(s) in Company | Oct. 10, 2025 |
| Holding(s) in Company | Oct. 10, 2025 |
Announcements
| $4m balance sheet improvement with bond conversion | Oct. 10, 2025 |
| CE Mark application submission | Oct. 01, 2025 |
| Update Regarding Forward Guidance | Sep. 24, 2025 |
| Additional Subscription for 11m Shares | Sep. 24, 2025 |
| Investor Presentation and Revised Revenue Guidance | Sep. 23, 2025 |
| Result of Fundraise | Sep. 22, 2025 |
| WRAP Retail Offer for up to £500,000 | Sep. 22, 2025 |